Ascari, S.; Chen, R.; Vivaldi, C.; Stefanini, B.; De Sinno, A.; Dalbeni, A.; Federico, P.; Tovoli, F., Advancements in immunotherapy for hepatocellular carcinoma, «EXPERT REVIEW OF ANTICANCER THERAPY», 2025, 25, pp. 151 - 165 [Scientific article]
Piscaglia, F.; Masi, G.; Martinelli, E.; Cabibbo, G.; Di Maio, M.; Gasbarrini, A.; Iavarone, M.; Antonuzzo, L.; Mazzaferro, V.; Ballestrero, A.; Garufi, C.; Bergamo, F.; Celsa, C.; Marino, D.; Tovoli, F.; Ponziani, F. R.; Pressiani, T.; Astolfi, C.; Gazzoli, G. C.; Ciardiello, F.; Daniele, B.; Rimassa, L., Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial, «ESMO OPEN», 2025, 10, pp. 1 - 10 [Scientific article]Open Access
Gramantieri, L.; Montagner, A.; Arleo, A.; Suzzi, F.; Bassi, C.; Tovoli, F.; Bruccoleri, M.; Alimenti, E.; Fornari, F.; Iavarone, M.; Negrini, M.; Piscaglia, F.; Giovannini, C., Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma, «ESMO OPEN», 2025, 10, Article number: 104289 , pp. 1 - 11 [Scientific article]Open Access
Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C., Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma, «EUROPEAN JOURNAL OF IMMUNOLOGY», 2024, 54, pp. 1 - 10 [Scientific article]Open Access
Chen, R.; Monaco, G.; Stefanini, B.; Marseglia, M.; De Lorenzo, S.; Tovoli, F., Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma, «CHINESE CLINICAL ONCOLOGY», 2024, 13, pp. 1 - 11 [Scientific article]Open Access
Ielasi L.; Stefanini B.; Conti F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Foschi F.G.; Piscaglia F.; Granito A.; Tovoli F., Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy, «CURRENT ONCOLOGY», 2024, 31, pp. 547 - 557 [Scientific article]Open Access
Stefanini, B.; Manfredi, G. F.; D'Alessio, A.; Fulgenzi, C. A. M.; Awosika, N.; Celsa, C.; Pirisi, M.; Rigamonti, C.; Burlone, M.; Vincenzi, F.; Minisini, R.; Gennari, A.; Yip, V.; Slater, S.; El-Shakankery, K.; Jain, A.; Tovoli, F.; Piscaglia, F.; Spalding, D.; Pai, M.; Pinato, D. J., Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2024, 18, pp. 647 - 660 [Scientific article]Open Access
Tovoli F.; Stefanini B.; Mandrioli D.; Mattioli S.; Vornoli A.; Sgargi D.; Manservisi F.; Piscaglia F.; Curti S.; Bolondi L., Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study, «DIGESTIVE AND LIVER DISEASE», 2024, 56, pp. 1 - 8 [Scientific article]Open Access
Rimini, M.; Stefanini, B.; Tada, T.; Suda, G.; Shimose, S.; Kudo, M.; Finkelmeier, F.; Yoo, C.; Presa, J.; Amadeo, E.; Genovesi, V.; Degrandis, M. C.; Iavarone, M.; Marra, F.; Foschi, F.; Tamburini, E.; Rossari, F.; Vitiello, F.; Bartalini, L.; Solda, C.; Tovoli, F.; Vivaldi, C.; Lonardi, S.; Silletta, M.; Kumada, T.; Sakamoto, N.; Iwamoto, H.; Aoki, T.; Himmelsbach, V.; Montes, M.; Hiraoka, A.; Sho, T.; Niizeki, T.; Nishida, N.; Steup, C.; Hirooka, M.; Kariyama, K.; Tani, J.; Atsukawa, M.; Takaguchi, K.; Itobayashi, E.; Fukunishi, S.; Tsuji, K.; Ishikawa, T.; Tajiri, K.; Ochi, H.; Yasuda, S.; Toyoda, H.; Ogawa, C.; Nishimura, T.; Hatanaka, T.; Kakizaki, S.; Shimada, N.; Kawata, K.; Tada, F.; Ohama, H.; Nouso, K.; Morishita, A.; Tsutsui, A.; Nagano, T.; Itokawa, N.; Okubo, T.; Arai, T.; Imai, M.; Kosaka, H.; Naganuma, A.; Koizumi, Y.; Nakamura, S.; Kaibori, M.; Iijima, H.; Hiasa, Y.; Persano, M.; Camera, S.; Foti, S.; Aldrighetti, L.; Cascinu, S.; Casadei-Gardini, A.; Piscaglia, F., Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab, «LIVER INTERNATIONAL», 2024, 44, pp. 1108 - 1125 [Scientific article]
Sansone, Vito; Auteri, Giuseppe; Tovoli, Francesco; Mazzoni, Camilla; Paglia, Simona; Di Pietro, Christian; Vianelli, Nicola; Cavo, Michele; Palandri, Francesca; Piscaglia, Fabio, Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis, «JOURNAL OF ULTRASOUND», 2024, 27, pp. 715 - 722 [Scientific article]
Melero, I.; Yau, T.; Kang, Y.-K.; Kim, T.-Y.; Santoro, A.; Sangro, B.; Kudo, M.; Hou, M.-M.; Matilla, A.; Tovoli, F.; Knox, J.; He, A.R.; El-Rayes, B.; Acosta-Rivera, M.; Lim, H.Y.; Soleymani, S.; Yao, J.; Neely, J.; Tschaika, M.; Hsu, C.; El-Khoueiry, A.B., Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040, «ANNALS OF ONCOLOGY», 2024, 35, pp. 537 - 548 [Scientific article]Open Access
Monti, Federico; Perazza, Federica; Leoni, Laura; Stefanini, Bernardo; Ferri, Silvia; Tovoli, Francesco; Zavatta, Guido; Piscaglia, Fabio; Petroni, Maria Letizia; Ravaioli, Federico, RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2024, 25, Article number: 9193 , pp. 1 - 15 [Scientific article]Open Access
Stefanini, Bernardo; Ielasi, Luca; Casadei-Gardini, Andrea; Piscopo, Michele; Tortora, Raffaella; Lani, Lorenzo; Pressiani, Tiziana; Sansone, Vito; Sacco, Rodolfo; Magini, Giulia; Renzulli, Matteo; Foschi, Francesco Giuseppe; Piscaglia, Fabio; Tovoli, Francesco; Granito, Alessandro, Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib, «GASTROENTEROLOGY INSIGHTS», 2024, 15, pp. 519 - 529 [Scientific article]
Tovoli, Francesco; Pallotta, Dante Pio; Vivaldi, Caterina; Campani, Claudia; Federico, Piera; Palloni, Andrea; Dalbeni, Andrea; Soldà, Caterina; Lani, Lorenzo; Svegliati-Baroni, Gianluca; Garajova, Ingrid; Ielasi, Luca; De Lorenzo, Stefania; Granito, Alessandro; Stefanini, Bernardo; Masi, Gianluca; Marra, Fabio; Lonardi, Sara; Brandi, Giovanni; Bruno, Daniele; Auriemma, Alessandra; Schiadà, Laura; Chen, Rusi; Piscaglia, Fabio, Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma, «DIGESTIVE AND LIVER DISEASE», 2024, 56, pp. 2079 - 2084 [Scientific article]Open Access
Ielasi, Luca; Stefanini, Bernardo; Piscaglia, Fabio; Granito, Alessandro; Tovoli, Francesco, A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival, «GASTROENTEROLOGY INSIGHTS», 2023, 14, pp. 38 - 44 [Scientific article]Open Access
